Participated · Series A · Mar 2026

Combat Medical develops device-assisted hyperthermic therapies designed to improve the delivery and efficacy of cancer chemotherapies, notably its HIVEC intravesical system for bladder cancer. The company has an installed base of over 350 systems and reports completion of more than 100,000 HIVEC treatments to date. Combat is running the HIVEC HEAT phase 3 pivotal trial aimed at FDA registration for treatment of BCG-unresponsive non-muscle-invasive bladder cancer. It also has clinical programs targeting peritoneal cancer (HIPEC) and plans to expand those as it scales. Recent financing (a £2.6 million Series A first close) is intended to fund the phase 3 trial and preparatory activities for U.S. regulatory submissions and commercial expansion. Management has stated it will pursue future financings to complete FDA registration and grow operations.

Participated · Series B · Dec 2019

Viridi Parente develops fail-safe, point-of-use lithium-ion battery systems for mobile and stationary applications. Its Green Machine brand supplies portable packs for construction and heavy industrial markets and has logged over 250,000 hours of field use. Its Volta Energy brand offers fail-safe stationary battery systems configurable from 50 kWh to 5 MW for data centers, manufacturing, commercial, medical, residential and other occupied spaces. The company emphasizes safety and resilience using materials and thermal management technologies derived from aerospace and military applications and is partnering with KULR Technology Group to integrate patented safety tech. Viridi aims to manufacture its fail-safe battery technology at scale and to repurpose abandoned manufacturing sites to create jobs in economically depressed urban areas. The company recently completed a significant financing to support increased production and broader market deployment. Viridi Parente manufactures renewable power systems that use proprietary lithium-ion cells, modules, and drives for industrial applications, microgrid storage, and replacements for fossil fuel–based engine systems. Through subsidiaries Green Machine Equipment (launched in 2010) and Volta Energy Products (founded in 2017), the company focuses on replacing diesel power sources and designing in-place distributed energy systems that provide instantaneous backup, peak shave demand costs, and a balanced energy profile. Led by Chairman & CEO Jon M. Williams, Viridi Parente develops systems for heavy machinery and storage applications and for microgrid deployments. The company is preparing to install its first distributed storage system to support a high-powered cryo-electron microscope at the Hauptman-Woodward Medical Research Institute in Buffalo. Financially, Viridi Parente secured a $29M Series B that values the company at approximately $80M. The round was led by Grand Oaks Capital with participation from Impact Capital of New York, Varia Ventures, the Western New York Impact Investment Fund, and private investors.